8RWB image
Deposition Date 2024-02-02
Release Date 2025-02-12
Last Version Date 2025-05-07
Entry Detail
PDB ID:
8RWB
Keywords:
IMMUNE SYSTEM
Title:
Crystal structure of ULBP6 in complex with a blocking antibody
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
synthetic construct (Taxon ID: 32630)
Host Organism:
Homo sapiens
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.31 Å
R-Value Free:
0.28
R-Value Work:
0.21
Space Group:
C 1 2 1
8RWB validation report
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Heavy chain
Chain IDs:B (auth: H)
Chain Length:217
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:Light chain
Chain IDs:C (auth: L)
Chain Length:212
Number of Molecules:1
Biological Source:synthetic construct
Protein Blast
Polymer Type:polypeptide(L)
Molecule:UL16-binding protein 6
Gene (Uniprot):RAET1L
Chain IDs:A (auth: P)
Chain Length:172
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:Q5VY80 Pfam ID:PF00129
Ligand Molecules
EDO
GOL
NAG
Primary Citation
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and Fc gamma RIIIa Activation.
Cancer Res Commun 5 476 495 (2025)
PMID: 40116579 DOI: 10.1158/2767-9764.CRC-24-0478

Abstact

This study emphasizes the utility of population-based genome-wide assessments for discovering naturally occurring genetic variants associated with lifetime risks for cancer or immune diseases as novel drug targets. We identify ULBP6 as a potential keystone member of the NKG2D pathway, which is important for antitumor immunity. Targeting ULBP6 may hold therapeutic promise for patients with cancer.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
8RWB